UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4461.25

Change

+24.75 (+0.56)%

Market Cap

N/A

Volume

7.49K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.60 (-1.25%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.08%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 640.06B
0R1I:LSE NVIDIA Corp.

-6.15 (-4.33%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.06 (-0.18%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

+0.90 (+1.27%)

USD 266.08B
0QZO:LSE 0QZO

+1.00 (+0.90%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.70 (-3.12%)

USD 202.26B
0R24:LSE Intel Corp.

-0.56 (-2.75%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.40% 92% A 87% B+
Dividend Return 0.01% 18% F 10% F
Total Return 21.41% 92% A 87% B+
Trailing 12 Months  
Capital Gain 13.12% 79% B- 74% C
Dividend Return 0.04% 29% F 25% F
Total Return 13.16% 77% C+ 73% C
Trailing 5 Years  
Capital Gain 67.84% 65% D 71% C-
Dividend Return 0.22% 30% F 40% F
Total Return 68.06% 62% D 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.41% 52% F 59% D-
Dividend Return 7.42% 51% F 58% F
Total Return 0.01% 21% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 10.35% 64% D 79% B-
Risk Adjusted Return 71.69% 73% C 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.